皮损CD8+T细胞数量预测白癜风黑素细胞-角质形成细胞移植手术结局
该研究纳入20例接受黑素细胞-角质形成细胞移植术(MKTP)的白癜风患者和1例斑驳病患者作为对照,术前检测受者皮肤T细胞亚群和趋化因子,术中量化供者皮肤黑素细胞,术后随访12个月评估复色。结果显示43%临床稳定皮损中CD8+T细胞升高,且CD8+T细胞数量与术后复色评分负相关(r=-0.635,P=0.002),而临床稳定持续时间、皮肤趋化因子和移植黑素细胞数量未影响复色。
要点
- 临床稳定的白癜风皮损中43%存在CD8+T细胞升高。
- CD8+T细胞数量与MKTP术后复色评分负相关(r=-0.635,P=0.002)。
- 临床稳定持续时间、趋化因子及移植黑素细胞数未影响复色。
核心结论
- CD8+T细胞数量与MKTP术后复色成功负相关,可作为识别理想手术候选者的生物标志物。
研究设计与样本
- 研究纳入20例接受MKTP的白癜风患者和1例斑驳病患者作为对照,术前用流式细胞术和ELISA检测受者皮肤T细胞亚群和趋化因子,术中流式细胞术量化供者皮肤黑素细胞,术后随访12个月临床和ImageJ分析照片评估复色。
主要发现
- 临床稳定的白癜风皮损中43%存在CD8+T细胞升高。
- CD8+T细胞数量与术后复色评分负相关(r=-0.635,P=0.002)。
- 临床稳定持续时间、皮肤趋化因子和移植黑素细胞数量未影响术后复色。
临床怎么用
- CD8+T细胞数量或可用于识别适合MKTP手术的白癜风候选者。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The melanocyte-keratinocyte transplantation procedure (MKTP) treats stable and recalcitrant vitiligo. Despite careful selection of candidates based on clinical stability, the success of the procedure is unpredictable. The aim of our study was to define the immunological profile of stable vitiligo lesions undergoing MKTP and correlate them with clinical outcomes. We included 20 MKTP candidates with vitiligo and a patient with piebaldism as a control. Prior to MKTP, T-cell subsets and chemokines in the recipient skin were measured by flow cytometry and ELISA. During MKTP, melanocytes in the donor skin were quantified by flow cytometry. After MKTP, patients were followed for 12 months and repigmentation was assessed clinically and by ImageJ analysis of clinical photographs. Baseline immunologic biomarkers, duration of clinical stability, and transplanted melanocyte number were correlated to postsurgical repigmentation scores. CD8+ T cells were elevated in 43% of the clinically stable vitiligo lesions. CD8+ T-cell number negatively correlated with postsurgical repigmentation scores (r = -0.635, P = 0.002). Duration of clinical stability, skin chemokines, and transplanted melanocyte number did not influence postsurgical repigmentation. This study demonstrates that CD8+ T-cell number correlates negatively with success of postsurgical repigmentation and can be a biomarker to identify ideal surgical candidates.
引用
- Refat MA, Strassner JP, Frisoli ML, et al. Lesional CD8+ T-Cell Number Predicts Surgical Outcomes of Melanocyte-Keratinocyte Transplantation Surgery for Vitiligo. J Invest Dermatol. 2023. PMID: 37478900. doi:10.1016/j.jid.2023.03.1689
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。